The central finding was the superior activity of a 2-antibody combination against the type 1 mutant CALR neoantigen. Dual ...

Study results indicate that mutation strength may shape both tumor–immune system interactions and immunotherapy response.

The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...

More than 30 types of muscular dystrophy have been identified. They all cause problems with movement due to muscle protein defects caused by genetic mutations. Muscular dystrophy is a group of ...